Publications by authors named "Vinod Parikh"

Claim this Profile
D
Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates.
Antonia F Stepan, Michelle M Claffey, Matthew R Reese, Gayatri Balan, Gabriela Barreiro, Vinod Parikh

J Med Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoproteomics demonstrates target engagement and exquisite selectivity of the clinical phosphodiesterase 10A inhibitor MP-10 in its native environment.
Jan-Philip Schülke, Laura A McAllister, Kieran F Geoghegan, Vinod Parikh, Thomas A Chappie

ACS Chem Biol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and clinical pharmacokinetics of 2-methyl-n-(2'-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1'-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools.
Aarti Sawant Basak, Wonkyung Byon, Elaine Tseng-Lovering, Carrie Funk, Linda Wood, Vinod Parikh

Xenobiotica· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions.
Jamison B Tuttle, Marie Anderson, Bruce M Bechle, Brian M Campbell, Cheng Chang, Vinod D Parikh

ACS Med Chem Lett· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia.
Amy B Dounay, Marie Anderson, Bruce M Bechle, Brian M Campbell, Michelle M Claffey, Vinod D Parikh

ACS Med Chem Lett· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and discovery of a selective small molecule κ opioid antagonist (2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine, PF-4455242).
Patrick R Verhoest, Aarti Sawant Basak, Vinod Parikh, Matthew Hayward, Gregory W Kauffman

J Med Chem· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A general strategy for the synthesis of cyclic N-aryl hydroxamic acids via partial nitro group reduction.
Laura A McAllister, Bruce M Bechle, Amy B Dounay, Edelweiss Evrard, Xinmin Gan, Vinod D Parikh

J Org Chem· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a series of (4,5-dihydroimidazol-2-yl)-biphenylamine 5-HT7 agonists.
Vinod Parikh, Willard M Welch, Anne W Schmidt

Bioorg Med Chem Lett· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis